Medifast Inc. (MED) Reports Q4 Miss; Guides Q1
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Join SI Premium – FREE
Medifast Inc. (NYSE: MED) reported Q4 EPS of $0.23, $0.09 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $63 million versus the consensus estimate of $64.67 million.
Sees Q1 revenue of $73.5-$74 million, versus the consensus of $80.70 million.
Sees Q1 revenue of $73.5-$74 million, versus the consensus of $80.70 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
